At ST3, we view every customer relationship as a partnership. Our customers entrust us with a critical component of their business: the reproducible manufacturing of their tissue-engineered medical product in a bioreactor system. Two key grant collaborations are highlighted below.
ST3 is pleased to announce its membership in the Advanced Regenerative Manufacturing Institute (ARMI) that was recently awarded $80M by the Department of Defense. We look forward to contributing our commercial bioreactor technological expertise to the project and advancing tissue biofabrication. More information about the project can be found here.
http://www.defense.gov/News/News-Releases/News-Release-View/Article/1035759/dod-announces-award-of-new-advanced-tissue-biofabrication-manufacturing-innovat
ST3 was awarded a Regenerative Medicine Minnesota Biobusiness grant to develop a pulsatile flow bioreactor in collaboration with Drs. Robert Tranquillo and Zeeshan Syedain from the University of Minnesota. More details about this project can be found here.
http://www.regenmedmn.org/regenerative-medicine-bioreactor-drive-system-development